Application of autologous stem cell transplantation in various adult and pediatric rheumatic diseases (Q37987428)

26 August 2017

title

Application of autologous stem cell transplantation in various adult and pediatric rheumatic diseases (English)

1 reference

stem cell transplantation

26 August 2017

main subject

1 reference

Alan Tyndall

1

1 reference

26 August 2017

language of work or name

English

0 references

publication date

22 February 2012

1 reference

26 August 2017

1 reference

26 August 2017

volume

71

1 reference

26 August 2017

issue

4 Pt 2

1 reference

26 August 2017

page(s)

433-438

1 reference

https://scigraph.springernature.com/pub.10.1038/pr.2011.66

26 August 2017

exact match

0 references

cites work

Autologous haemopoietic stem cell transplantation in a patient with severe pulmonary hypertension complicating connective tissue disease

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.66

Blood and marrow stem cell transplants in auto-immune disease: a consensus report written on behalf of the European League against Rheumatism (EULAR) and the European Group for Blood and Marrow Transplantation (EBMT)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.66

Depletion of autoreactive immunologic memory followed by autologous hematopoietic stem cell transplantation in patients with refractory SLE induces long-term remission through de novo generation of a juvenile and tolerant immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.66

Thymic output generates a new and diverse TCR repertoire after autologous stem cell transplantation in multiple sclerosis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.66

Regulatory T cells in autologous stem cell transplantation for autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.66

Capillary regeneration in scleroderma: stem cell therapy reverses phenotype?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.66

Autologous non-myeloablative haemopoietic stem-cell transplantation compared with pulse cyclophosphamide once per month for systemic sclerosis (ASSIST): an open-label, randomised phase 2 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.66

Autologous Stem cell Transplantation International Scleroderma (ASTIS) trial: hope on the horizon for patients with severe systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.66

Inflammatory and autoimmune mechanisms in the induction of atherosclerotic damage in systemic rheumatic diseases: Two faces of the same coin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.66

Minimal T-cell requirements for triggering haemophagocytosis associated with Epstein-Barr virus-driven B-cell proliferation: a clinical case study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.66

Acquired hemophilia-A in a patient with multiple sclerosis treated with autologous hematopoietic stem cell transplantation and interferon beta-1a

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.66

Outcome of intensive immunosuppression and autologous stem cell transplantation in patients with severe rheumatoid arthritis is associated with the composition of synovial T cell infiltration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.66

Successful autologous stem cell transplantation in two patients with juvenile dermatomyositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.66

Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.66

Multipotent mesenchymal stromal cells for autoimmune diseases: teaching new dogs old tricks.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.66

Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.66

Monocyte chemotactic protein-1 secreted by primary breast tumors stimulates migration of mesenchymal stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.66

EMT: when epithelial cells decide to become mesenchymal-like cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.66

Fibroblast growth factor 2 and platelet-derived growth factor, but not platelet lysate, induce proliferation-dependent, functional class II major histocompatibility complex antigen in human mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.66

Clinical-grade production of human mesenchymal stromal cells: occurrence of aneuploidy without transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.66

Bone marrow mesenchymal stromal cells (BM-MSCs) from healthy donors and auto-immune disease patients reduce the proliferation of autologous- and allogeneic-stimulated lymphocytes in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.66

The survey on cellular and engineered tissue therapies in Europe in 2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.66

The therapeutic potential of mesenchymal stem cell transplantation as a treatment for multiple sclerosis: consensus report of the International MSCT Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.66

Bone marrow mesenchymal stem cell transplantation in patients with multiple sclerosis: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.66

Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.66

Non-expanded adipose stromal vascular fraction cell therapy for multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.66

Expanded adipose-derived stem cells for the treatment of complex perianal fistula: a phase II clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.66

Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn's disease: results of a phase I study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.66

Autologous progenitor cell implantation as a novel therapeutic intervention for ischaemic digits in systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.66

Mesenchymal stem cell transplantation for diffuse alveolar hemorrhage in SLE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.66

Transplantation of placenta-derived mesenchymal stem cells in type 2 diabetes: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.66

Autologous mesenchymal stem cells foster revascularization of ischemic limbs in systemic sclerosis: a case report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.66

Skin involvement in scleroderma--where histological and clinical scores meet

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.66

Treatment of systemic sclerosis with autologous haemopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.66

Autologous hematopoietic stem cell transplantation for autoimmune diseases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.66

Nail fold capillaroscopy differs widely between systemic sclerosis and chronic graft vs host disease of the skin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.66

Immunology. Replacing an immune system gone haywire

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.66

Stem cells: HSCT for systemic sclerosis--swallows and summers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.66

Autologous stem cell transplantation in children with severe progressive systemic or polyarticular juvenile idiopathic arthritis: long-term follow-up of a prospective clinical trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.66

Current perspectives of autologous stem cell transplantation for severe Juvenile Idiopathic Arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.66

Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.66

31 March 2020

All MSCs are pericytes?

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.66

Why do we need noncommercial, investigator-initiated clinical trials?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.66

Rapid improvement of nailfold capillaroscopy after intense immunosuppression for systemic sclerosis and mixed connective tissue disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.66

Allogeneic mesenchymal stem cells transplantation in treatment of multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.66

Autologous bone marrow-derived mesenchymal stromal cells in the treatment of fistulising Crohn's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.66

Marked improvement of severe progressive systemic sclerosis after transplantation of mesenchymal stem cells from an allogeneic haploidentical-related donor mediated by ligation of CD137L

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.66

Allogenic mesenchymal stem cells transplantation in refractory systemic lupus erythematosus: a pilot clinical study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.66

Umbilical cord mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.66

Autologous mesenchymal stem cell treatment increased T regulatory cells with no effect on disease activity in two systemic lupus erythematosus patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.66

31 March 2020

Identifiers

DOI

10.1038/PR.2011.66

1 reference

Dimensions Publication ID

26 August 2017

1042175079

0 references

1 reference